Barfod N M
Cancer Res. 1982 Jun;42(6):2420-5.
Eight endogenous G1 inhibitors of the proliferation of JB-1 ascites tumor cells have been isolated and characterized. The activity of the inhibitors has been analyzed on synchronized JB-1 (murine plasmacytoma) and L1A2 (murine sarcoma) cells in vitro using flow cytometry. The purified inhibitors have been tested for in vivo activity on partially synchronized JB-1 and L1A2 ascites tumors in situ. Four of the inhibitors exhibited a high degree of cell specificity (chalone-like inhibitors) and were chemically related, whereas the other four showed no cell specificity. In most extractions, the amount of cell-specific activity is more than 50% of the total G1-inhibitory activity. Most of the inhibitors are low-molecular-weight peptides and glycopeptides.
已分离并鉴定出八种抑制JB-1腹水肿瘤细胞增殖的内源性G1抑制剂。使用流式细胞术在体外对同步化的JB-1(鼠浆细胞瘤)和L1A2(鼠肉瘤)细胞分析了这些抑制剂的活性。已对纯化的抑制剂在原位部分同步化的JB-1和L1A2腹水肿瘤上进行了体内活性测试。其中四种抑制剂表现出高度的细胞特异性(类抑素样抑制剂)且在化学上相关,而另外四种则没有细胞特异性。在大多数提取物中,细胞特异性活性的量占总G1抑制活性的50%以上。大多数抑制剂是低分子量肽和糖肽。